Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole

Andrea CALCAGNO; Alice TRENTALANGE; MARCO SIMIELE; Letizia MARINARO; FRANCESCA PATTI; Maria C Tettoni; Laura TRENTINI; Giovanni DI PERRI; ANTONIO D'AVOLIO; Stefano BONORA

doi:10.1097/FTD.0000000000000200

Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole

Andrea CALCAGNO
, Alice TRENTALANGE
, MARCO SIMIELE
, Letizia MARINARO
, FRANCESCA PATTI
, Maria C Tettoni
, Laura TRENTINI
, Giovanni DI PERRI
, ANTONIO D'AVOLIO
, Stefano BONORA

Dipartimento di Medicina Traslazionale

Risultato della ricerca: Contributo su rivista › Articolo in rivista › peer review

Lingua originale	Inglese
pagine (da-a)	695-696
Numero di pagine	2
Rivista	Therapeutic Drug Monitoring
Volume	37
Numero di pubblicazione	5
DOI	https://doi.org/10.1097/FTD.0000000000000200
Stato di pubblicazione	Pubblicato - 2015

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

2-Pyridinylmethylsulfinylbenzimidazoles
Anti-HIV Agents
Drug Interactions
HIV Infections
Humans
Liver Cirrhosis
Male
Middle Aged
Rilpivirine

Accesso al documento

10.1097/FTD.0000000000000200

https://hdl.handle.net/11579/216916

Altri file e collegamenti

handle

Cita questo

CALCAGNO, A., TRENTALANGE, A., SIMIELE, MARCO., MARINARO, L., PATTI, FRANCESCA., Tettoni, M. C., TRENTINI, L., DI PERRI, G., D'AVOLIO, ANTONIO., & BONORA, S. (2015). Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole. Therapeutic Drug Monitoring, 37(5), 695-696. https://doi.org/10.1097/FTD.0000000000000200

@article{51fdcd99ced94b13a1416599c8fe3421,

title = "Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole",

keywords = "2-Pyridinylmethylsulfinylbenzimidazoles, Anti-HIV Agents, Drug Interactions, HIV Infections, Humans, Liver Cirrhosis, Male, Middle Aged, Rilpivirine, 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-HIV Agents, Drug Interactions, HIV Infections, Humans, Liver Cirrhosis, Male, Middle Aged, Rilpivirine",

author = "Andrea CALCAGNO and Alice TRENTALANGE and MARCO SIMIELE and Letizia MARINARO and FRANCESCA PATTI and Tettoni, \{Maria C\} and Laura TRENTINI and \{DI PERRI\}, Giovanni and ANTONIO D'AVOLIO and Stefano BONORA",

year = "2015",

doi = "10.1097/FTD.0000000000000200",

language = "English",

volume = "37",

pages = "695--696",

journal = "Therapeutic Drug Monitoring",

issn = "0163-4356",

publisher = "Lippincott Williams and Wilkins",

number = "5",

}

CALCAGNO, A, TRENTALANGE, A, SIMIELE, MARCO, MARINARO, L, PATTI, FRANCESCA, Tettoni, MC, TRENTINI, L, DI PERRI, G, D'AVOLIO, ANTONIO & BONORA, S 2015, 'Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole', Therapeutic Drug Monitoring, vol. 37, n. 5, pagg. 695-696. https://doi.org/10.1097/FTD.0000000000000200

TY - JOUR

T1 - Rilpivirine Pharmacokinetics in 3 HIV-Positive Patients With Liver Cirrhosis Concomitantly Receiving Pantoprazole

AU - CALCAGNO, Andrea

AU - TRENTALANGE, Alice

AU - SIMIELE, MARCO

AU - MARINARO, Letizia

AU - PATTI, FRANCESCA

AU - Tettoni, Maria C

AU - TRENTINI, Laura

AU - DI PERRI, Giovanni

AU - D'AVOLIO, ANTONIO

AU - BONORA, Stefano

PY - 2015

Y1 - 2015

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Anti-HIV Agents

KW - Drug Interactions

KW - HIV Infections

KW - Humans

KW - Liver Cirrhosis

KW - Male

KW - Middle Aged

KW - Rilpivirine

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Anti-HIV Agents

KW - Drug Interactions

KW - HIV Infections

KW - Humans

KW - Liver Cirrhosis

KW - Male

KW - Middle Aged

KW - Rilpivirine

UR - https://iris.uniupo.it/handle/11579/216916

U2 - 10.1097/FTD.0000000000000200

DO - 10.1097/FTD.0000000000000200

M3 - Article

SN - 0163-4356

VL - 37

SP - 695

EP - 696

JO - Therapeutic Drug Monitoring

JF - Therapeutic Drug Monitoring

IS - 5

ER -